Investing7d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
As Illumina transitions to its new NovaSeq X platform and implements cost-cutting ... Management is aiming for a double-digit plus earnings per share (EPS) compound annual growth rate (CAGR ...
Yahoo Finance26d
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
The combination of Illumina's Single Cell Prep, NovaSeq™ X Plus platform, 25B flow cell and DRAGEN™ analysis software creates a seamless end-to-end workflow enabling the high-throughput ...
Investing15d
Citi analysts foresee downside for Illumina stock amid challenges
This partnership combines Illumina’s Single Cell Prep and NovaSeq™ X Plus platform with Broad Clinical Labs’ expertise, promising to transform the scale of single-cell sample processing.
Pharmabiz23d
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
The combination of Illumina's Single Cell Prep, NovaSeq X Plus platform, 25B flow cell and DRAGEN analysis software creates a seamless end-to-end workflow enabling the high-throughput processing of ...
Yahoo Finance23d
ILMN Stock Might Rise From Collaboration With Broad Clinical Labs
Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the ...
Case Western Reserve University22d
Our Services
The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...
Investing7d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
As Illumina transitions to its new NovaSeq X platform and implements cost-cutting measures ... Management is aiming for a double-digit plus earnings per share (EPS) compound annual growth rate (CAGR) ...